Skip to search formSkip to main contentSkip to account menu

alamifovir

Known as: Bis(2,2,2-trifluoroethyl) ((2-{2-amino-6-((4-methoxyphenyl)sulfanyl)-9H-purin-9-yl}ethoxy)methyl)phosphonate 
A purine nucleotide analog prodrug with activity against wild-type and lamivudine-resistant hepatitis B virus (HBV). Alamifovir acts by inhibiting… 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (2)

LY 582563MCC 478

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Determination of alamifovir disoproxil fumarate and its active metabolite 602076 in rat plasma by LC-MS/MS: application to a pharmacokinetic study.
2011
2011
etermination of alamifovir disoproxil fumarate and its active metabolite 02076 in rat plasma by LC – MS / MS : Application to a pharmacokinetic study
Alamifovir disoproxil fumarate (ADF) is a novel ester prodrug of alamifovir, which is currently as a promising antiviral… 
2010
2010
Design,synthesis and biological activity of prodrugs of alamifovir analogs
Aim To design and synthesize new alamifovir analogs prodrugs.Methods The target compounds were synthesized via chloromethylation… 
2005
2005
Clinical Pharmacokinetics of Alamifovir and Its Metabolites
ABSTRACT Alamifovir, a purine nucleotide analogue prodrug, and its hydrolyzed derivatives have shown preclincal efficacy activity… 
2004
2004
Safety and efficacy of alamifovir in patients with chronic hepatitis B virus infection.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)